FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog The Pharmacology of Longevity: Peptide Edition (Part 1) Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York